Incruse Ellipta (product)
| Code | 12221201000001100 |
|---|---|
| Semantic tag | product |
| Module | uk-clinical |
| Definition | primitive |
| Effective time | 20141112 |
9191801000001103Trade family
product
37439611000001101Incruse Ellipta 55micrograms/dose dry powder inhaler (CST Pharma Ltd)
real clinical drug
38140511000001104Incruse Ellipta 55micrograms/dose dry powder inhaler (DE Pharmaceuticals)
real clinical drug
37666611000001102Incruse Ellipta 55micrograms/dose dry powder inhaler (Ethigen Ltd)
real clinical drug
27567911000001101Incruse Ellipta 55micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd)
real clinical drug
37511511000001102Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd)
real clinical drug
37989411000001108Incruse Ellipta 55micrograms/dose dry powder inhaler (Pharmaram Ltd)
real clinical drug